Immunogenic dying cells elicit potent anti-tumor T cell immunity against lung metastasis and tumorigenesis by Min Hu, Xinyu Meng, Tong Wang, Yifan Wang, Xiaodong Chen, Dongliang Xu, Wei He, Hongjia Zhang, Wenzheng Guo, Bo Jing, Siwei Zhang, Jianhua Xu, Beibei Sun, Xueqian Sun, Tingting Liu, Na Ni, Tongtong Zhang, Wenwen Cui, Xiaoyu Wu, Liping Xia, Feng Yao, Fang Zhang, Jing Du, Jiong Deng

Subjects: Get full text

Tissue‐resident memory T cells in diseases and therapeutic strategies by Daoyuan Xie, Guanting Lu, Gang Mai, Qiuyan Guo, Guofeng Xu

Subjects: Get full text

Modeling COVID-19 dynamics in the Basque Country: characterizing population immunity profile from 2020 to 2022 by Bechir Naffeti, Zeineb Ounissi, Akhil Kumar Srivastav, Nico Stollenwerk, Joseba Bidaurrazaga Van-Dierdonck, Maíra Aguiar

Subjects: Get full text

SARS-COV-2 re-infection and incidence of post-acute sequelae of COVID-19 (PASC) among essential workers in New York: a retrospective cohort studyResearch in context by Tesleem K. Babalola, Sean A.P. Clouston, Zennur Sekendiz, Devi Chowdhury, Nicola Soriolo, Joseph Kawuki, Jaymie Meliker, Melissa Carr, Bruno R. Valenti, Ashley Fontana, Onix A. Melendez, Olga Morozova, Benjamin J. Luft

Subjects: Get full text

Oral Immunisation With Non‐GMO Surface Displayed SARS‐CoV‐2 Spike Epitopes on Bacteria‐Like Particles Provokes Robust Humoral and Cellular Immune Responses, and Modulated the Gut M... by Robie Vasquez, Ji Hoon Song, Remilyn M. Mendoza, In‐Chan Hwang, Bernadette B. Bagon, Lars Engstrand, Valerie Diane Valeriano, Dae‐Kyung Kang

Subjects: Get full text

Stochastic epidemic models with a backward bifurcation by Linda J. S. Allen, P. van den Driessche

Subjects: Get full text

Spatial epidemiology based on the analysis of COVID-19 in Africa by Joyce Akhalakwa Mukolwe, John Kamwele Mutinda, Amos Kipkorir Langat

Subjects: Get full text

Editorial: Antigen presentation in cancer immune responses by Marie-Liesse Asselin-Labat, Marie-Liesse Asselin-Labat, Megan K. Ruhland, Megan K. Ruhland, Stephen T. Ferris

Subjects: Get full text

Treatment approaches in advanced penile cancer: targeted therapies and immunotherapy by David J. Benjamin, Robert C. Hsu

Subjects: Get full text

Community acceptance of services and effectiveness of health camps in high-risk areas of Karachi, Sindh, Pakistan, 2021 by Fayaz Hussain Abbasi, Jaishri Mehraj, Azeem Khowaja, Irshad Ali Sodhar, Shoukat Ali Chandio, Shumaila Rasool, Shumaila Rasool, Asif Ali Zardari, Imtiaz Hussain, Altaf Bosan, Erin M. Stuckey, Ahmed Ali Shaikh, Ahmed Ali Shaikh

Subjects: Get full text

Virus-Mimicking Polymer Nanocomplexes Co-Assembling HCV E1E2 and Core Proteins with TLR 7/8 Agonist—Synthesis, Characterization, and In Vivo Activity by Thomas R. Fuerst, Alexander Marin, Sarah Jeong, Liudmila Kulakova, Raman Hlushko, Katrina Gorga, Eric A. Toth, Nevil J. Singh, Alexander K. Andrianov

Subjects: Get full text

Youth and the pandemic: health information imaginaries and practices while navigating COVID-19 in Nigeria by Chikezie E. Uzuegbunam

Subjects: Get full text

Recruitment of Young Gay, Bisexual, and Other Men Who Have Sex With Men for a Web-Based Human Papillomavirus Vaccination Intervention: Differences in Participant Characteristics and Study Engagement by Recruitment Source in a Randomized Controlled Trial by Daniel J Marshall, Amy L Gower, Mira L Katz, José A Bauermeister, Abigail B Shoben, Paul L Reiter

“…These participants also spent a longer amount of time viewing intervention content about HPV vaccination (3.14 minutes vs 2.67 minutes; P=.02). …”
Get full text

Protocol for a multicentre randomised controlled trial examining the effects of temporarily pausing Bruton tyrosine kinase inhibitor therapy to coincide with SARS-CoV-2 vaccination and its impact on immune responses in patients with chronic lymphocytic leukaemia by Abhishek Abhishek, Jonathan A Cook, Helen M Parry, Anne Francis, Lelia Duley, Vicki S Barber, Paul Moss, Nicholas Peckham

“…Introduction People who are immunocompromised have a poor biological response to vaccinations. This study aims to determine in patients with chronic lymphocytic leukaemia (CLL) if a 3-week pause in Bruton tyrosine kinase inhibitor therapy (BTKi) starting 1 week before delivery of SARS-CoV-2 vaccine booster, improves vaccine immune response when compared with continuation of BTKi.Methods and analysis An open-label, randomised controlled superiority trial will be conducted in haematology clinics in approximately 10 UK National Health Service (NHS) hospitals. …”
Get full text

Mass rabies exposure of veterinary health care workers in Germany: Management, immune response, and tolerability of post exposure-prophylaxis by Lennart Lemmermann, Jonathan Remppis, Sabine Bélard, Florian Steiner

Subjects: Get full text

Studies on development of early immunity against type O FMD in naturally susceptible animals by D. V. Mikhalishin, D. A. Lozovoy, V. A. Starikov, Yu. S. El’kina, M. I. Doronin, A. V. Borisov

Subjects: “…inactivated monovalent emulsion vaccine…”
Get full text

The evolution, facilitators, barriers, and additional activities of acute flaccid paralysis surveillance platform in polio eradication programme Bangladesh: a mixed-method study by Humayra Binte Anwar, Yameen Mazumder, Sanjana Nujhat, Bushra Zarin Islam, Anna Kalbarczyk, Olakunle Alonge, Malabika Sarker

Subjects: Get full text

Newcastle Disease Virus Displaying an Ectodomain of Middle East Respiratory Syndrome Coronavirus Spike Protein Elicited Robust Humoral and Cellular Immunity in Mice by Jaturawitt Prasopsiri, Kanjana Srisutthisamphan, Benjamas Liwnaree, Juggragarn Jengarn, Jarin Kramyu, Payuda Hansoongnern, Papon Muangsanit, Nathiphat Tanwattana, Challika Kaewborisuth, Suttipun Sungsuwan, Anan Jongkaewwattana, Nanchaya Wanasen

Subjects: Get full text

Impact of Obesity-Associated SARS-CoV-2 Mutations on COVID-19 Severity and Clinical Outcomes by Ana B. Martínez-Martinez, Alexander Tristancho-Baró, Beatriz Garcia-Rodriguez, Marina Clavel-Millan, Maria Pilar Palacian, Ana Milagro, Antonio Rezusta, Jose M. Arbones-Mainar

Subjects: Get full text

Nanostructured lipid carriers based mRNA vaccine leads to a T cell–inflamed tumour microenvironment favourable for improving PD-1/PD-L1 blocking therapy and long-term immunity in a cold tumour modelResearch in context by Carole Fournier, Marion Mercey-Ressejac, Valentin Derangère, Amal Al Kadi, David Rageot, Christine Charrat, Alexis Leroy, Julien Vollaire, Véronique Josserand, Marie Escudé, Séverine Escaich, François Ghiringhelli, Thomas Decaens, Fabrice P. Navarro, Evelyne Jouvin-Marche, Patrice N. Marche

Subjects: “…mRNA vaccine…”
Get full text